GLSI Insider Buying Signals Confidence Amid Volatile Valuation
Insider buying of Greenwich Lifesciences (GLSI) shows CEO‑CFO confidence in a high‑valuation oncology pipeline despite negative earnings, urging investors to watch upcoming clinical milestones and market access moves.
4 minutes to read